Q2 STOCKS TO BUY

Altria, Amazon, Catabasis News Today

Today's stocks to watch in the news include Altria Group Inc (MO), Amazon.com, Inc. (AMZN), and Catabasis Pharmaceuticals Inc (CATB)

Feb 1, 2017 at 10:02 AM
facebook X logo linkedin


U.S. stocks are higher, after a better-than-expected ADP employment report. Among specific equities in the spotlight are tobacco company Altria Group Inc (NYSE:MO), e-tail behemoth Amazon.com, Inc. (NASDAQ:AMZN), and biotech stock Catabasis Pharmaceuticals Inc (NASDAQ:CATB). Here's a quick look at what's driving MO, AMZN, and CATB.

Altria Falls On Forecast

MO is trading down 2% at $69.76, after announcing weaker-than-expected fourth-quarter sales and issuing 2017 guidance under analyst expectations. Still, Altria shares have managed to recover more than 14% from their post-election lows, and just yesterday notched a record high of $71.44. In the option pits, near-term traders have been more call-skewed than usual, with Altria Group Inc's Schaeffer's put/call open interest ratio (SOIR) of 0.55 sitting in just the 19th percentile of its annual range.

Amazon to Open New Cincinnati Shipping Hub

AMZN -- which reports earnings tomorrow -- is up 0.8% at $830.25, following news that the e-tail giant will open a new air cargo hub at the Cincinnati/Northern Kentucky airport, bringing the company one step closer to its goal of becoming an autonomous force among shipping companies. The project will cost around $1.5 billion, and will create upwards of 2,700 new jobs. AMZN is up more than 43% year-over-year, though the shares have stalled near the $840-$850 mark, home to AMZN's all-time high, notched in early October. Analyst sentiment towards Amazon.com, Inc. is mostly upbeat, with 28 of 31 rating the shares a "buy" or better.

Catabasis Plunges On DMD Drug Disappointment

CATB is down a whopping 70% at $1.22 -- and just off a new all-time low of $1.08 -- after the biotech reported disappointing mid-stage trial results for its Duchenne muscular dystrophy (DMD) drug, edasalonexent. Catabasis Pharmaceuticals Inc shares also received a downgrade to "market perform" from "outperform" from Cowen and Company, as well as a brutal 87% price-target cut -- to $4 from $30. Likewise, Oppenheimer cut its target price on the shares to $11 from $18. Before today's drop, the shares had enjoyed a floor near the $3.50 mark, though the stock is now down more than 80% year-over-year. A number of short sellers are likely cheering today's drop, however, with CATB's short interest up more than 24% in the last two reporting periods.

Get a jump-start on the day's stock market news with Schaeffer's free Opening View newsletter.

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter